BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.0643
+0.0013 (1.98%)
Aug 21, 2025, 1:37 PM EDT
BetterLife Pharma Market Cap
BetterLife Pharma has a market cap or net worth of $9.97 million as of August 21, 2025. Its market cap has decreased by -7.66% in one year.
Market Cap
9.97M
Enterprise Value
13.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since October 4, 2010, BetterLife Pharma's market cap has decreased from 98.33M to 9.97M, a decrease of -89.87%. That is a compound annual growth rate of -14.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 9.97M | 6.78% |
| Dec 31, 2024 | 9.33M | 68.00% |
| Dec 29, 2023 | 5.55M | -49.28% |
| Dec 30, 2022 | 10.95M | -24.42% |
| Dec 31, 2021 | 14.49M | -81.78% |
| Dec 31, 2020 | 79.55M | 302.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 614.68M |
| Glass House Brands | 554.44M |
| American Oncology Network | 385.65M |
| CytoDyn | 360.07M |
| Northwest Biotherapeutics | 355.76M |